Aphelion Capital

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.

Laplace Interventional is a medical device company focused on developing transcatheter tricuspid valve technology aimed at treating tricuspid regurgitation. The company's innovative prosthetic valve is delivered through a minimally invasive procedure, eliminating the need for open-heart surgery. This approach not only enhances patients' life expectancy but also significantly improves their quality of life by reducing the risk of future complications. Through its advancements in cardiac care, Laplace Interventional is dedicated to providing effective solutions for patients worldwide.

Venova Medical specializes in developing vascular access systems aimed at improving the experience of patients requiring renal replacement therapy, particularly those needing hemodialysis. Founded in 2018 and based in Los Gatos, California, the company focuses on overcoming challenges related to vascular access creation. By addressing both patient-level and systemic barriers, Venova Medical provides solutions that facilitate quicker functioning access with reduced need for intervention. This approach not only enhances vascular access outcomes but also aims to lower associated costs, ultimately simplifying the process for patients in need of hemodialysis.

Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, that focuses on treating mid-sized abdominal aortic aneurysms. Founded in 2017, the company has developed an innovative treatment designed to stabilize the growth of aneurysms and prevent their rupture. This treatment delivers a compound containing a stabilizer agent directly to the aneurysm site, which helps inhibit further breakdown and strengthens the vessel wall. By providing a safer intervention option, Nectero Medical aims to enable patients to receive timely care, significantly delaying or preventing the need for major endovascular or surgical repair.

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.

Phagenesis Limited is focused on developing medical device technology aimed at treating dysphagia, a condition that impairs swallowing, often resulting from strokes or brain injuries. The company's primary product, Phagenyx, consists of a base station that delivers electrical stimulations to the patient and records pertinent information, along with a catheter that is introduced through the nose to stimulate the pharynx. This innovative approach leverages the brain's ability to relearn lost functions through neuroplasticity, effectively aiding patients in regaining control over their swallowing mechanisms. Founded in 2007 and based in Manchester, United Kingdom, Phagenesis emphasizes research and evidence-based solutions, with foundational work led by Professor Shaheen Hamdy of the University of Manchester, whose findings have been published in prestigious medical journals.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

Elucid, located in the Boston biotech and medtech hub, specializes in enhancing the accuracy and cost-effectiveness of cardiovascular diagnostic imaging through machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software that evaluates plaque vulnerability from a single computed tomography angiography (CTA) scan, aiding in the assessment of heart attack and stroke risk as well as treatment selection. The company also collaborates with pharmaceutical firms, healthcare providers, and research organizations to offer quantitative image analysis services. By applying artificial intelligence to vascular diagnostics, Elucid aims to improve patient outcomes while providing a non-invasive and economically efficient means of capturing critical health information, thereby supporting cardiovascular pathologists in delivering comprehensive clinical insights.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

ExplORer Surgical Corp. develops an interactive surgical playbook that enhances teamwork and communication in the operating room. Founded in 2013 and based in Chicago, Illinois, the company offers a software solution that allows healthcare providers to compare performance, track case progression in real time, and forecast various operational metrics, such as staffing and equipment use. The platform provides customizable surgical workflows tailored to patient needs and surgeon preferences, minimizing disruptions and reducing waste. By facilitating coordination among surgical teams and offering real-time performance data, the software improves efficiency and quality of care, enabling medical professionals to focus on successful procedures. Additionally, ExplORer Surgical aids medical device companies in the rollout of new devices, contributing to improved medical education and operational cost savings.

MIVI Neuroscience, Inc. is a medical device company based in Eden Prairie, Minnesota, that specializes in developing and commercializing solutions for neurointerventional procedures. Founded in 2013, the company offers a range of innovative products designed to enhance patient outcomes by improving the safety and efficacy of treatments for ischemic stroke. Its product portfolio includes high flow tubing, diagnostic and guide catheters, and aspiration pumps, as well as embolic protection and clot retrieval devices. MIVI Neuroscience aims to reduce complications and procedure times, thereby expanding treatment options for healthcare professionals and their patients.

Koya Medical, Inc., founded in 2018 and based in Oakland, California, specializes in developing innovative therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. The company focuses on creating wearable technology that delivers active compression therapy, which is designed to enhance movement and mobility for patients. Koya Medical's approach offers a personalized alternative to traditional compression methods, utilizing a sensor-based closed-loop system to provide tailored compression patterns. This technology addresses the needs of patients suffering from conditions such as lymphedema, chronic edema, and chronic venous insufficiency, thereby improving their quality of care and overall treatment outcomes.

Orpyx Medical Technologies Inc. specializes in developing mobility sensor devices aimed at diabetic patients. The company's flagship product, the Orpyx SI sensory insoles, employs advanced sensor technology to monitor pressure, temperature, and movement, thereby helping to manage and prevent diabetic foot ulcers and limb loss. Additionally, Orpyx offers Kinetyx, a mobile in-shoe pressure management system that captures clinical plantar pressure data for sports medicine and footwear design, along with SurroGait Rx, which aids multiple sclerosis patients in enhancing mobility and balance. Founded in 2010 and headquartered in Calgary, Canada, Orpyx Medical Technologies is committed to empowering individuals with diabetes to maintain their mobility while promoting a prevention-focused healthcare model.

Zeto Inc. is a medical technology company based in Santa Clara, California, focused on revolutionizing electroencephalography (EEG) practices in hospitals. Established in 2014, Zeto has developed an innovative dry electrode EEG system that features a wireless, easy-to-wear headset designed to enhance patient experience and streamline the EEG process. This system is the first of its kind to receive FDA clearance, eliminating the need for extensive preparation and specialized technicians. It significantly reduces setup time from over 30 minutes to just five, allowing for quicker and more efficient EEG interpretation. The accompanying digital platform offers instant data upload, live viewing capabilities, and analytical tools, enabling remote analysis by neurologists. Zeto has gained recognition for its advancements in EEG technology, receiving multiple awards, including funding from the Epilepsy Foundation and accolades for innovation in medical technology.

ExplORer Surgical Corp. develops an interactive surgical playbook that enhances teamwork and communication in the operating room. Founded in 2013 and based in Chicago, Illinois, the company offers a software solution that allows healthcare providers to compare performance, track case progression in real time, and forecast various operational metrics, such as staffing and equipment use. The platform provides customizable surgical workflows tailored to patient needs and surgeon preferences, minimizing disruptions and reducing waste. By facilitating coordination among surgical teams and offering real-time performance data, the software improves efficiency and quality of care, enabling medical professionals to focus on successful procedures. Additionally, ExplORer Surgical aids medical device companies in the rollout of new devices, contributing to improved medical education and operational cost savings.

Bardy Diagnostics, Inc. is a medical device company that specializes in the development and manufacturing of cardiac monitoring solutions, primarily focused on arrhythmia detection. Its flagship product, the Carnation Ambulatory Monitor (CAM), is a lightweight, discreet cardiac patch that can be worn comfortably for up to seven days, even during physical activities like exercise or showering. The CAM is designed with a unique hourglass shape to enhance comfort, particularly for female patients. Complementing the monitor is the BDxCONNECT patient management system, which allows healthcare providers to create and manage patient reports efficiently. By utilizing innovative P-wave centric ECG detection technology, Bardy Diagnostics aims to improve clinical management and outcomes for patients and their physicians. Founded in 2013, the company is headquartered in Seattle, Washington, with additional offices in Houston, Texas, and New Providence, New Jersey.

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.

Providence Medical Technology is a medical device company dedicated to developing innovative solutions for cervical spine conditions in the United States and internationally. The company specializes in the design of surgical instrumentation and implants that address cervical degenerative disc disease through a unique approach to indirect decompression and fusion. Its primary offerings include the DTRAX Spinal System, which consists of single-use disposable instruments for accessing the spine via posterior incisions, and the DTRAX Cervical Cage, designed to treat cervical radiculopathy by facilitating indirect decompression and fusion. Additionally, the company provides the DTRAX Graft, a structural allograft for posterior fusion support, and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.

ExplORer Surgical Corp. develops an interactive surgical playbook that enhances teamwork and communication in the operating room. Founded in 2013 and based in Chicago, Illinois, the company offers a software solution that allows healthcare providers to compare performance, track case progression in real time, and forecast various operational metrics, such as staffing and equipment use. The platform provides customizable surgical workflows tailored to patient needs and surgeon preferences, minimizing disruptions and reducing waste. By facilitating coordination among surgical teams and offering real-time performance data, the software improves efficiency and quality of care, enabling medical professionals to focus on successful procedures. Additionally, ExplORer Surgical aids medical device companies in the rollout of new devices, contributing to improved medical education and operational cost savings.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.

Providence Medical Technology is a medical device company dedicated to developing innovative solutions for cervical spine conditions in the United States and internationally. The company specializes in the design of surgical instrumentation and implants that address cervical degenerative disc disease through a unique approach to indirect decompression and fusion. Its primary offerings include the DTRAX Spinal System, which consists of single-use disposable instruments for accessing the spine via posterior incisions, and the DTRAX Cervical Cage, designed to treat cervical radiculopathy by facilitating indirect decompression and fusion. Additionally, the company provides the DTRAX Graft, a structural allograft for posterior fusion support, and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.

Providence Medical Technology is a medical device company dedicated to developing innovative solutions for cervical spine conditions in the United States and internationally. The company specializes in the design of surgical instrumentation and implants that address cervical degenerative disc disease through a unique approach to indirect decompression and fusion. Its primary offerings include the DTRAX Spinal System, which consists of single-use disposable instruments for accessing the spine via posterior incisions, and the DTRAX Cervical Cage, designed to treat cervical radiculopathy by facilitating indirect decompression and fusion. Additionally, the company provides the DTRAX Graft, a structural allograft for posterior fusion support, and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

CyMedica Orthopedics, Inc. is a medical device company focused on developing and commercializing innovative products for joint injuries and the associated muscle atrophy. Founded in 2013 and based in Scottsdale, Arizona, CyMedica offers a range of orthopedic solutions that utilize proprietary neuromuscular electrical stimulation technology. Its flagship product, e-vive, provides individualized muscle stimulation therapy through a wireless and app-controlled system, allowing patients to engage in their rehabilitation while tracking progress and sharing data with clinicians. Additionally, the company offers a variety of products, including the Conductive garment, which ensures effective muscle activation, the ACL Brace for post-operative support, and The QB1 System, designed to empower patients in overcoming quadricep weakness. These devices aim to stabilize joints, prevent muscle weakening during recovery, and improve patient outcomes while reducing the likelihood of readmission.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.

Providence Medical Technology is a medical device company dedicated to developing innovative solutions for cervical spine conditions in the United States and internationally. The company specializes in the design of surgical instrumentation and implants that address cervical degenerative disc disease through a unique approach to indirect decompression and fusion. Its primary offerings include the DTRAX Spinal System, which consists of single-use disposable instruments for accessing the spine via posterior incisions, and the DTRAX Cervical Cage, designed to treat cervical radiculopathy by facilitating indirect decompression and fusion. Additionally, the company provides the DTRAX Graft, a structural allograft for posterior fusion support, and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

Mercator MedSystems, Inc. is a medical technology company based in Emeryville, California, specializing in catheter-guided microfluid injection systems for the targeted delivery of therapeutic agents. The company offers Cricket and Bullfrog micro-infusion catheters, which facilitate the direct injection of therapies through blood vessel walls into deep tissues. These products address conditions such as blood vessel restenosis, inflammation following vascular injury, and peripheral artery disease. Mercator's technology allows for the infusion of drugs, genes, and cells without compromising their viability or potency, making it suitable for therapies ranging from plaque stabilization in diseased vessels to stem cell transplantation and gene therapies. By enabling site-specific delivery, Mercator MedSystems aims to enhance patient outcomes in vascular disease, oncology, and regenerative medicine, while paving the way for innovative treatments in these areas. The company was established in 1999 and was previously known as Endobionics, Inc.

VideoCare, Inc. specializes in technology solutions that help families stay connected with their aging loved ones. The company offers a user-friendly touch-screen video system designed specifically for elderly care recipients, eliminating the need for keyboards or technical skills. This system allows users to share photos, videos, music, and social media content while also managing medication, appointments, and daily activities. VideoCare facilitates remote face-to-face interactions, enabling family members and professional caregivers to provide support and companionship. Additionally, home care agencies and elder facilities can use the platform to enhance connectivity between care recipients and their families or staff. Founded in 2011 and based in Menlo Park, California, VideoCare aims to improve the quality of life for seniors by fostering meaningful connections.

SurgiQuest is a technology company based in Orange, Connecticut, specializing in solutions for minimally invasive surgery. Established in 2006, the company is known for its AirSeal technology, which creates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest's focus spans various surgical fields, including bariatric, colorectal, general, gynecological, and urologic surgery.

ClearFlow, Inc. is a medical device company specializing in the development and manufacturing of active blood and fluid evacuation systems to address catheter obstructions. The company's primary product, the PleuraFlow Active Clearance Technology system, is designed to clear chest tubes, preventing the retention of blood and fluids in the chest cavity, particularly for pediatric cardiothoracic surgery patients. This innovative technology allows for improved postoperative blood evacuation, enabling the use of minimally invasive drainage tubes, which can enhance patient comfort and reduce surgical complications. ClearFlow is expanding its product pipeline based on its proprietary technologies to tackle catheter clogging across various medical segments, including urinary and gastrointestinal catheters, as well as wound drainage. Founded in 2006 and based in Anaheim, California, the company also operates a service center in Maastricht, the Netherlands.

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

SurgiQuest is a technology company based in Orange, Connecticut, specializing in solutions for minimally invasive surgery. Established in 2006, the company is known for its AirSeal technology, which creates an air curtain to maintain an insufflated and airtight environment during laparoscopic and laparoscopic-assisted procedures. SurgiQuest's focus spans various surgical fields, including bariatric, colorectal, general, gynecological, and urologic surgery.

iHear Medical, Inc. is a California-based company focused on providing affordable and accessible hearing solutions. Established in 2010 and headquartered in San Leandro, the company offers a range of web-enabled hearing aids and sound amplifiers, including the iHEARhd and iHEARMAX, which cater to varying degrees of hearing loss. iHear Medical addresses the significant gap in hearing aid usage, as only 14% of individuals with hearing loss currently use them, largely due to high costs and stigma. The company also developed the iHEARtest, an FDA-cleared at-home hearing screener that allows consumers to assess their hearing and determine the appropriate hearing aid solution based on a proprietary Hearing Number. The iHEARtest is available online and at select retail pharmacies. With over 50 patents submitted and a commitment to innovation, iHear Medical aims to enhance the quality of life for those with hearing loss through its comprehensive product offerings and services.

Ikanos Communications, Inc. designs and develops semiconductor and integrated firmware products for the connected home on a global scale. The company specializes in digital subscriber line (DSL) processors and a variety of semiconductor solutions tailored for carrier infrastructure and customer premises equipment. Its offerings include gateway processors that facilitate high-speed access and value-added services for connected homes, as well as multi-mode communications processors for residential gateways. These products support diverse network topologies such as DSL, Ethernet, and LTE, serving telecommunications carriers and cable operators. Ikanos markets its products through direct sales and through partnerships with network equipment manufacturers, original design manufacturers, and distributors. Established in 1999 and based in Fremont, California, Ikanos Communications operates as a subsidiary of Qualcomm Atheros, Inc.

OrthoScan, Inc. is a medical device company based in Scottsdale, Arizona, specializing in the development and manufacture of orthopedic imaging devices. Founded in 2002, the company focuses on providing innovative solutions for anatomical visualization in surgical settings. Its product line includes the ORTHOSCAN FD PULSE, a flat detector C-arm that enhances field of view for surgeons, and the ORTHOSCAN MOBILE DI unit, designed for mobility between various clinical environments. Other offerings include the ORTHOSCAN FD-OR for optimal positioning in surgery, the ORTHOSCAN HD mini C-arm, and accessories such as mini drapes and protective aprons. OrthoScan aims to improve the efficiency and effectiveness of imaging in orthopedic procedures, catering to the needs of healthcare professionals in both surgical and clinical contexts.

Corium International, Inc. is a biopharmaceutical company based in Menlo Park, California, that specializes in the development, manufacture, and commercialization of specialty pharmaceutical products utilizing transdermal and transmucosal delivery systems. The company offers a range of products, including the Clonidine Transdermal Delivery System for hypertension, Fentanyl TDS for chronic pain management, and Crest Whitestrips for teeth whitening. Corium's pipeline includes Twirla, a hormonal contraceptive patch; MicroCor hPTH(1-34) for severe osteoporosis; and transdermal systems for Alzheimer's treatment, among others. Additionally, the company is advancing projects for psychiatric disorders and Parkinson's disease. Corium collaborates with several pharmaceutical companies, enhancing its research and development capabilities. The firm is recognized for its proprietary delivery technologies that improve therapeutic outcomes and safety profiles across various therapeutic areas.

StrataGent Life Sciences, Inc. is a specialty drug therapy company focused on creating painless and non-invasive alternatives to injectable therapies. The company's innovative products utilize proprietary microjet technology, which enables the delivery of both large and small therapeutic molecules without the need for devices to penetrate the skin. This approach aims to enhance patient comfort and compliance in medical treatments. StrataGent's commitment to advancing its technology was recognized in May 2004, when the company received a $2 million award from the Advanced Technology Program at the National Institute of Standards and Technology to further develop its microjet technology.

VasoNova, Inc. is a medical device company based in Sunnyvale, California, specializing in the development and marketing of vascular navigation systems for healthcare providers. The company has created a self-guided PICC catheter and offers the VasoNova Vascular Positioning System, an algorithm-based system designed to assist clinicians in the optimal placement of vascular access devices. Through its innovative technologies, VasoNova aims to enhance the efficiency and effectiveness of vascular access procedures in medical settings.

Insulet Corporation is a medical device company established in 2000 and headquartered in Acton, Massachusetts. The company specializes in the development, manufacturing, and marketing of insulin delivery systems for individuals with insulin-dependent diabetes. Its flagship product, the Omnipod System, comprises a small, disposable, tubeless insulin infusion device that adheres to the skin and a wireless personal diabetes manager, which can be operated via smartphone to facilitate dosage control. The Omnipod System offers a pain-free automated cannula insertion and is designed to enhance the diabetes management experience for users. Insulet distributes its products primarily through independent distributors, pharmacy channels, and direct sales in the United States, Canada, Europe, and the Middle East. Since receiving FDA approval in 2005, the Omnipod System has been adopted by approximately 425,000 users worldwide, reflecting Insulet's commitment to improving the lives of those managing diabetes.

Ikanos Communications, Inc. designs and develops semiconductor and integrated firmware products for the connected home on a global scale. The company specializes in digital subscriber line (DSL) processors and a variety of semiconductor solutions tailored for carrier infrastructure and customer premises equipment. Its offerings include gateway processors that facilitate high-speed access and value-added services for connected homes, as well as multi-mode communications processors for residential gateways. These products support diverse network topologies such as DSL, Ethernet, and LTE, serving telecommunications carriers and cable operators. Ikanos markets its products through direct sales and through partnerships with network equipment manufacturers, original design manufacturers, and distributors. Established in 1999 and based in Fremont, California, Ikanos Communications operates as a subsidiary of Qualcomm Atheros, Inc.

Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.